Mirae Asset Global Investments
VRTX icon

Mirae Asset Global Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$64.4M Buy
144,588
+1,270
+0.9% +$565K 0.22% 86
2025
Q1
$69.5M Buy
143,318
+23,769
+20% +$11.5M 0.28% 71
2024
Q4
$48.4M Buy
119,549
+17,264
+17% +$6.99M 0.2% 94
2024
Q3
$47.3M Buy
102,285
+10,016
+11% +$4.64M 0.21% 89
2024
Q2
$43.6M Sell
92,269
-208,587
-69% -$98.6M 0.22% 81
2024
Q1
$105M Buy
300,856
+4,178
+1% +$1.46M 0.23% 83
2023
Q4
$121M Sell
296,678
-21,922
-7% -$8.92M 0.25% 82
2023
Q3
$111M Buy
318,600
+41,032
+15% +$14.3M 0.24% 81
2023
Q2
$97.7M Sell
277,568
-7,331
-3% -$2.58M 0.21% 92
2023
Q1
$89.8M Sell
284,899
-20,923
-7% -$6.59M 0.21% 93
2022
Q4
$88.3M Sell
305,822
-14,145
-4% -$4.08M 0.23% 94
2022
Q3
$92.7M Sell
319,967
-15,755
-5% -$4.56M 0.25% 74
2022
Q2
$94.6M Buy
335,722
+11,222
+3% +$3.16M 0.24% 76
2022
Q1
$84.7M Buy
324,500
+39,313
+14% +$10.3M 0.18% 123
2021
Q4
$62.7M Buy
285,187
+37,357
+15% +$8.21M 0.13% 170
2021
Q3
$45M Buy
247,830
+78,091
+46% +$14.2M 0.11% 226
2021
Q2
$34.2M Sell
169,739
-161,348
-49% -$32.5M 0.1% 262
2021
Q1
$71.1M Sell
331,087
-179,437
-35% -$38.6M 0.25% 88
2020
Q4
$121M Buy
510,524
+312,239
+157% +$73.8M 0.45% 39
2020
Q3
$53.5M Buy
198,285
+23,102
+13% +$6.24M 0.27% 77
2020
Q2
$50.9M Sell
175,183
-89,068
-34% -$25.9M 0.31% 58
2020
Q1
$62.9M Buy
264,251
+177,194
+204% +$42.2M 0.49% 37
2019
Q4
$19.1M Buy
87,057
+22,228
+34% +$4.87M 0.12% 209
2019
Q3
$11M Buy
64,829
+7,812
+14% +$1.32M 0.08% 287
2019
Q2
$10.4M Buy
57,017
+309
+0.5% +$56.1K 0.07% 291
2019
Q1
$10.4M Buy
56,708
+2,805
+5% +$514K 0.08% 247
2018
Q4
$8.93M Buy
53,903
+6,203
+13% +$1.03M 0.08% 263
2018
Q3
$9.15M Buy
47,700
+12,772
+37% +$2.45M 0.07% 291
2018
Q2
$5.61M Buy
34,928
+2,678
+8% +$430K 0.08% 163
2018
Q1
$5.26M Buy
32,250
+2,960
+10% +$483K 0.07% 178
2017
Q4
$4.39M Sell
29,290
-1,518
-5% -$228K 0.06% 200
2017
Q3
$4.66M Buy
30,808
+10,071
+49% +$1.52M 0.08% 176
2017
Q2
$2.66M Buy
20,737
+1,861
+10% +$239K 0.05% 259
2017
Q1
$2.06M Buy
18,876
+13,953
+283% +$1.52M 0.04% 275
2016
Q4
$363K Sell
4,923
-4,759
-49% -$351K 0.01% 436
2016
Q3
$844K Sell
9,682
-607
-6% -$52.9K 0.02% 372
2016
Q2
$885K Sell
10,289
-110
-1% -$9.46K 0.02% 330
2016
Q1
$827K Sell
10,399
-11,806
-53% -$939K 0.02% 351
2015
Q4
$2.8M Buy
22,205
+15,764
+245% +$1.98M 0.09% 180
2015
Q3
$670K Sell
6,441
-350
-5% -$36.4K 0.03% 331
2015
Q2
$838K Buy
6,791
+220
+3% +$27.1K 0.03% 330
2015
Q1
$775K Buy
6,571
+1,187
+22% +$140K 0.03% 338
2014
Q4
$639K Buy
5,384
+12
+0.2% +$1.42K 0.02% 322
2014
Q3
$604K Buy
+5,372
New +$604K 0.02% 336
2013
Q3
Sell
-6,715
Closed -$538K 445
2013
Q2
$538K Buy
+6,715
New +$538K 0.03% 337